Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TYCHE INDUSTRIES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TYCHE INDUSTRIES   MYLAN
EQUITY SHARE DATA
    TYCHE INDUSTRIES
Mar-23
MYLAN
Dec-18
TYCHE INDUSTRIES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1633,978-   
Low Rs1052,190-   
Sales per share (Unadj.) Rs73.51,830.6-  
Earnings per share (Unadj.) Rs13.849.7-  
Cash flow per share (Unadj.) Rs15.6392.5-  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs113.91,980.4-  
Shares outstanding (eoy) m10.25514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.81.7 108.1%   
Avg P/E ratio x9.762.0 15.6%  
P/CF ratio (eoy) x8.67.9 109.5%  
Price / Book Value ratio x1.21.6 75.5%  
Dividend payout %14.50-   
Avg Mkt Cap Rs m1,3721,586,770 0.1%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m700-   
Avg. sales/employee Rs Th026,910.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.7-  
INCOME DATA
Net Sales Rs m754941,863 0.1%  
Other income Rs m480-   
Total revenues Rs m802941,863 0.1%   
Gross profit Rs m160243,719 0.1%  
Depreciation Rs m18176,354 0.0%   
Interest Rs m045,300 0.0%   
Profit before tax Rs m19122,065 0.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m49-3,510 -1.4%   
Profit after tax Rs m14225,575 0.6%  
Gross profit margin %21.325.9 82.2%  
Effective tax rate %25.7-15.9 -161.8%   
Net profit margin %18.82.7 692.3%  
BALANCE SHEET DATA
Current assets Rs m1,219525,936 0.2%   
Current liabilities Rs m210383,465 0.1%   
Net working cap to sales %133.915.1 885.2%  
Current ratio x5.81.4 423.8%  
Inventory Days Days1384 15.0%  
Debtors Days Days1,06993 1,145.5%  
Net fixed assets Rs m192182,706 0.1%   
Share capital Rs m102501 20.4%   
"Free" reserves Rs m1,0650-   
Net worth Rs m1,1681,018,924 0.1%   
Long term debt Rs m01,099,746 0.0%   
Total assets Rs m1,4112,733,150 0.1%  
Interest coverage x19,085.01.5 1,283,383.4%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.50.3 155.0%   
Return on assets %10.02.6 387.3%  
Return on equity %12.12.5 483.6%  
Return on capital %16.33.2 514.1%  
Exports to sales %57.90-   
Imports to sales %19.90-   
Net fx Rs m2750-   
CASH FLOW
From Operations Rs m68195,719 0.0%  
From Investments Rs m19-101,165 -0.0%  
From Financial Activity Rs m-15-91,177 0.0%  
Net Cashflow Rs m721,621 4.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.58 Rs / USD

Compare TYCHE INDUSTRIES With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare TYCHE INDUSTRIES With: PHAARMASIA  KILITCH DRUGS  EARUM PHARMACEUTICALS  MEDPLUS HEALTH SERVICES  SYNCOM HEALTHCARE  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.